Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SPRAVATO 28 MG / 2 ACT

ESKETAMINE (ESKETAMINE HYDROCHLORIDE) : 28 MG / 2 ACT · DIN 02499290 · JANSSEN INC

Health Canada status: MARKETED

What is SPRAVATO?

SPRAVATO 28 MG / 2 ACT contains ESKETAMINE (ESKETAMINE HYDROCHLORIDE) : 28 MG / 2 ACT. It is listed in the Health Canada Drug Product Database under DIN 02499290, held by JANSSEN INC, supplied as SOLUTION for NASAL administration. Health Canada currently lists it as marketed, status dated 11-Jun-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02499290
Brand nameSPRAVATO
Generic / active ingredientESKETAMINE (ESKETAMINE HYDROCHLORIDE) : 28 MG / 2 ACT
ManufacturerJANSSEN INC
Strength28 MG / 2 ACT
Dosage formSOLUTION
Route of administrationNASAL
ScheduleNARCOTICS (CDSA I)
ATC codeN06AX27 ESKETAMINE
AHFS class10:00.00
BiosimilarNo
Health Canada statusMARKETED
Status date11-Jun-2020
Original market date2021-03-04 00:00:00

Who else supplies ESKETAMINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. ESKETAMINE appears in 33 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for SPRAVATO

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for SPRAVATO

Health Canada Drug Product Database (DPD), DIN 02499290. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.